Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptics”

813 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 813 results

Large-scale testing (Phase 3)Study completedNCT00167154
What this trial is testing

Risperidone and Suicidality in Major Depressive Disorder

Who this might be right for
Depression
University of Alabama at Birmingham 30
Large-scale testing (Phase 3)UnknownNCT03284294
What this trial is testing

Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia

Who this might be right for
Schizophrenia
Universitas Padjadjaran 40
Large-scale testing (Phase 3)Looking for participantsNCT05431595
What this trial is testing

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

Who this might be right for
DeliriumEpilepticsNeuroleptics
M.D. Anderson Cancer Center 42
Not applicableStudy completedNCT00999895
What this trial is testing

A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 574
Post-approval studies (Phase 4)UnknownNCT02040883
What this trial is testing

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

Who this might be right for
Schizophrenia
Qingyun Yin 100
Post-approval studies (Phase 4)UnknownNCT02562287
What this trial is testing

Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder

Who this might be right for
Bipolar Disorder
Hospital de Clinicas de Porto Alegre 54
Testing effectiveness (Phase 2)Ended earlyNCT04421456
What this trial is testing

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Who this might be right for
Schizophrenia
Jazz Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT00253136
What this trial is testing

The Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 458
Post-approval studies (Phase 4)Study completedNCT00014001
What this trial is testing

CATIE- Schizophrenia Trial

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 1,600
Early research (Phase 1)Study completedNCT02184767
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

Who this might be right for
BiPolar
Teva Branded Pharmaceutical Products R&D, Inc. 30
Not applicableUnknownNCT04784572
What this trial is testing

Assessment of Pain During Intramuscular Injection Delay in Adult Psychiatry

Who this might be right for
Delayed Antipsychotic Treatment, Pharmacological Factors and Individual Factors
Centre hospitalier de Ville-Evrard, France 393
Post-approval studies (Phase 4)UnknownNCT00182494
What this trial is testing

Diabetes Prevention Program in Schizophrenia [DPPS]

Who this might be right for
Diabetes MellitusSchizophrenia
Hamilton Health Sciences Corporation 200
Not applicableTemporarily pausedNCT00636753
What this trial is testing

Antipsychotics and Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
Glostrup University Hospital, Copenhagen 60
Not applicableEnrolling By InvitationNCT05165316
What this trial is testing

European Long-acting Antipsychotics in Schizophrenia Trial-II

Who this might be right for
Schizophrenia
Rene Kahn 400
Not applicableStudy completedNCT01686815
What this trial is testing

Cross-Sectional Iloperidone IVGTT

Who this might be right for
SchizophreniaSerious Mental IllnessMetabolic Syndrome+2 more
Massachusetts General Hospital 37
Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Post-approval studies (Phase 4)Study completedNCT01284959
What this trial is testing

Different Safety Profile of Risperidone and Paliperidone Extended-release

Who this might be right for
Schizophrenia
Chonbuk National University Hospital 34
Not applicableStudy completedNCT01139463
What this trial is testing

Study of Blood Lactate Levels in Patients Treated With Antipsychotics

Who this might be right for
Movement DisordersLactic Acidosis
University of Split 60
Not applicableStudy completedNCT00903916
What this trial is testing

Effect of Antipsychotics on Appetite Regulation

Who this might be right for
Psychotic Disorders
University of North Carolina, Chapel Hill 45
Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Next Page